These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23865644)

  • 1. Randomized, community-based pharmacy intervention to expand services beyond sale of sterile syringes to injection drug users in pharmacies in New York City.
    Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
    Am J Public Health; 2013 Sep; 103(9):1579-82. PubMed ID: 23865644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community Impact of Pharmacy-Randomized Intervention to Improve Access to Syringes and Services for Injection Drug Users.
    Crawford ND; Amesty S; Rivera AV; Harripersaud K; Turner A; Fuller CM
    Health Educ Behav; 2014 Aug; 41(4):397-405. PubMed ID: 24722219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A community-based approach to linking injection drug users with needed services through pharmacies: an evaluation of a pilot intervention in New York City.
    Rudolph AE; Standish K; Amesty S; Crawford ND; Stern RJ; Badillo WE; Boyer A; Brown D; Ranger N; Orduna JM; Lasenburg L; Lippek S; Fuller CM
    AIDS Educ Prev; 2010 Jun; 22(3):238-51. PubMed ID: 20528131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City.
    Fuller CM; Galea S; Caceres W; Blaney S; Sisco S; Vlahov D
    Am J Public Health; 2007 Jan; 97(1):117-24. PubMed ID: 17138929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple access to sterile syringes for injection drug users: vending machines, needle exchange programs and legal pharmacy sales in Marseille, France.
    Moatti JP; Vlahov D; Feroni I; Perrin V; Obadia Y
    Eur Addict Res; 2001 Mar; 7(1):40-5. PubMed ID: 11316925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
    Taussig JA; Weinstein B; Burris S; Jones TS
    AIDS; 2000 Jun; 14 Suppl 1():S47-51. PubMed ID: 10981474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of injection drug users accessing syringes from pharmacies, syringe exchange programs, and other syringe sources to inform targeted HIV prevention and intervention strategies.
    Rudolph AE; Crawford ND; Ompad DC; Benjamin EO; Stern RJ; Fuller CM
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):140-7. PubMed ID: 20199954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI.
    Zaller N; Jeronimo A; Bratberg J; Case P; Rich JD
    J Urban Health; 2010 Dec; 87(6):942-53. PubMed ID: 21116724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.
    Wright-De Agüero L; Weinstein B; Jones TS; Miles J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S102-10. PubMed ID: 9663632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.
    Lewis CF; Rivera AV; Crawford ND; DeCuir J; Amesty S
    Drug Alcohol Depend; 2015 Aug; 153():72-7. PubMed ID: 26118831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
    Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
    BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
    Bluthenthal RN; Malik MR; Grau LE; Singer M; Marshall P; Heimer R;
    Addiction; 2004 Sep; 99(9):1136-46. PubMed ID: 15317634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
    Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
    Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
    J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
    Lurie P; Jones TS; Foley J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S45-51. PubMed ID: 9663623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.